Biotecnología
Biotecnología
Ono, Admid Partner on Novel Antibody Drugs in Oncology
28/09/2023 -
Ono will evaluate and develop antibody product candidates at the preclinical and clinical stages.
Theradaptive Awarded DOD Clinical Trial Award of up to $7.4M
28/09/2023 -
Award will help Theradaptive scale up the production of its OsteoAdapt regenerative therapeutic product for spine and trauma repair.
Ginkgo Bioworks, Pfizer Enter Multi-Target RNA Discovery Alliance
28/09/2023 -
Pfizer will leverage Ginkgo's RNA technology for the discovery and development of novel RNA molecules across priority research areas.
Flexan, ILC Dover Earn Class 7 Certification for Cleanroom in Mexico
28/09/2023 -
Nearshoring strategy supports increased customer demand while upholding stringent quality standards.
Everads, Kriya Partner on Ocular Gene Therapy Candidates
28/09/2023 -
To use Everads' suprachoroidal delivery platform that enables non-surgical delivery to the back of the eye via the suprachoroidal space.
Merck KGaA Enters Strategic AI-driven Discovery Alliances
27/09/2023 -
Partnerships with BenevolentAI and Exscientia aimed at driving accelerated drug discovery with higher probability of success.
AcuraStem, Takeda Partner to Advance PIKFYVE Therapeutics
27/09/2023 -
Takeda will receive an exclusive license to AcuraStem’s PIKFYVE program, a therapeutic target for ALS and potentially Frontotemporal Dementia.
MedRhythms Selects Curavit for MR-001 Trial in Stroke Impairment
27/09/2023 -
Curavit is responsible for managing all aspects of MedRhythms’ hybrid decentralized clinical trial.
Chime Biologics, Kings Pharm Partner to Accelerate Biosimilar Launch
27/09/2023 -
Chime will provide cell line development, process development, global GMP manufacturing, commercialization, and regulatory filing support.
Pharmanovia Acquires Global CNS Portfolio from Sanofi
27/09/2023 -
Expands neurology portfolio with the acquisition of 11 central nervous system brands.
Valneva Signs $32M IXIARO Supply Pact with U.S. Government
27/09/2023 -
Deal includes possibility of purchasing additional doses during the next twelve months.
Charnwood Molecular Rebrands to Charnwood Discovery
27/09/2023 -
Specializes in enhancing the experience and success of complex drug discovery for clients.
Pierre Fabre, Vernalis Enter Oncology Drug Discovery Alliance
27/09/2023 -
Aims to identify preclinical candidates against multiple oncology targets.
Mikart Expands Production and Packaging Capabilities
27/09/2023 -
Acquires FlexPack NF-150 Horizontal Sachet-Packaging machine for clinical and commercial manufacturing.
Eftilagimod Cleared for Clinical Trial Use in the UK
27/09/2023 -
Comparability of drug substance and drug product manufactured at 2,000L scale achieved.
Veranova Names William Sanders Global VP of Chemical Development Ops
27/09/2023 -
Sanders has over 25 years of experience in the chemical and pharmaceutical industries.
Chime, Panolos Partner to Advance Multi-specific Therapeutic Proteins
27/09/2023 -
Chime will provide development and manufacturing services to Panolos Bioscience for PB203.
Emmes Names Peter Ronco CEO
27/09/2023 -
Ronco held R&D leadership positions over more than two decades, including senior vice president, global development at J&J.
Abbott Labs, mAbxience Enter Biosimilars Mfg. Pact
27/09/2023 -
mAbxience will manufacture the biosimilars at its GMP approved facilities in Spain and Argentina.
WuXi Vaccines Launches Vaccines CDMO Site in China
27/09/2023 -
Aims to add drug substance and drug product capacity, with services for diversified vaccines.
Societal CDMO Announces Corporate Restructuring
27/09/2023 -
Reduces 9% of workforce in an effort to right size the organization and save $5.5 million annually.
